Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Net Income Loss of -$83.78 million for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -33.8% in Net Income Loss from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2002 to 2024 (23 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 23 years of available data (2002 to 2024), NORTHWEST BIOTHERAPEUTICS INC's Net Income Loss has declined by 554.3%.
- Historical annual values: Fiscal year 2024: -$83.78 million | Fiscal year 2023: -$62.60 million | Fiscal year 2022: -$105.03 million | Fiscal year 2021: $179.13 million | Fiscal year 2020: -$529.82 million | Fiscal year 2019: -$20.81 million | Fiscal year 2018: -$35.79 million | Fiscal year 2017: -$73.14 million | Fiscal year 2016: -$80.21 million | Fiscal year 2015: -$114.74 million | Fiscal year 2014: -$135.63 million | Fiscal year 2013: -$65.79 million | Fiscal year 2012: -$67.32 million | Fiscal year 2011: -$32.83 million | Fiscal year 2010: -$27.37 million | Fiscal year 2009: -$26.95 million | Fiscal year 2008: -$22.33 million | Fiscal year 2007: -$21.25 million | Fiscal year 2006: -$1.40 million | Fiscal year 2005: -$9.94 million | Fiscal year 2004: -$8.51 million | Fiscal year 2003: -$5.75 million | Fiscal year 2002: -$12.80 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: